Regulated Antigen Expression in Live RecombinantSalmonella entericaSerovar Typhimurium Strongly Affects Colonization Capabilities and Specific CD4+-T-Cell Responses
- 1 December 2001
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 69 (12) , 7493-500
- https://doi.org/10.1128/iai.69.12.7493-7500.2001
Abstract
Regulated antigen expression can influence the immunogenicity of live recombinantSalmonellavaccines, but a rational optimization has remained difficult since important aspects of this effect are incompletely understood. Here, attenuatedSalmonella entericaserovar Typhimurium SL3261 strains expressing the model antigen GFP_OVA were used to quantify in vivo antigen levels by flow cytometry and to simultaneously follow the crucial early steps of antigen-specific T-cell responses in mice that are transgenic for a T-cell receptor recognizing ovalbumin. Among seven tested promoters,PpagChas the highest activity in murine tissues combined with low in vitro expression, whereasPtachas a comparable in vivo and a very high in vitro activity. Both SL3261 (pPpagCGFP_OVA) and SL3261 (pPtacGFP_OVA) cells can induce potent ovalbumin-specific cellular immune responses following oral administration, but doses almost 1,000-fold lower are sufficient for the in vivo-inducible construct SL3261 (pPpagCGFP_OVA) compared to SL3261 (pPtacGFP_OVA). This efficacy difference is largely explained by impaired early colonization capabilities of SL3261 (pPtacGFP_OVA) cells. Based on the findings of this study, appropriate in vivo expression levels for any given antigen can be rationally selected from the increasing set of promoters with defined properties. This will allow the improvement of recombinantSalmonellavaccines against a wide range of pathogens.Keywords
This publication has 45 references indexed in Scilit:
- In Vivo Visualization of Bacterial Colonization, Antigen Expression, and Specific T-Cell Induction following Oral Administration of Live RecombinantSalmonella entericaSerovar TyphimuriumInfection and Immunity, 2001
- Safety and Immune Responses to Attenuated Salmonella enterica Serovar Typhi Oral Live Vector Vaccines Expressing Tetanus Toxin Fragment CClinical Immunology, 2000
- Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicanaVaccine, 1998
- Fluorescence-Based Isolation of Bacterial Genes Expressed Within Host CellsScience, 1997
- The phoP locus influences processing and presentation of Salmonella typhimurium antigens by activated macrophagesMolecular Microbiology, 1995
- Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectorsVaccine, 1993
- Use of the nirB Promoter to Direct the Stable Expression of Heterologous Antigens in Salmonella Oral Vaccine Strains: Development of a Single–Dose Oral Tetanus VaccineNature Biotechnology, 1992
- Induction by Antigen of Intrathymic Apoptosis of CD4 + CD8 + TCR lo Thymocytes in VivoScience, 1990
- The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody.The Journal of Experimental Medicine, 1983
- Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccinesNature, 1981